Venus Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
775.00
16.1 (2.12%)
BSENSE

Dec 19

BSE+NSE Vol: 21.19 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 568580,
    "name": "Venus Remedies",
    "stock_name": "Venus Remedies",
    "full_name": "Venus Remedies Ltd",
    "name_url": "stocks-analysis/venus-remedies",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "775.00",
    "chg": 16.1,
    "chgp": "2.12%",
    "dir": 1,
    "prev_price": "758.90",
    "mcapval": "982.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526953,
    "symbol": "VENUSREM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE411B01019",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "21.19 k",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venus-remedies-568580-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/venus-remedies-568580-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Venus Remedies falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-venus-remedies-fallingrising-3761749",
        "imagepath": "",
        "date": "2025-12-18 01:01:12",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Venus Remedies’ share price dropped by ₹28.15 on 17-Dec, marking a 3.53% decrease from the previous close. Intraday, the stock touched a low of ₹758.40, representing a 4.86% fall from its prior levels. This decline is significant given the stock’s recent outperformance relative to the broader market and its sector peers. Over the past week, the stock has declined by 2.23%, while the Sensex benchmark index gained 0.20%, indicating that Venus Remedies underperformed the market in the short term.</p>\n<p>Despite this recent dip, the stock’s longer-term returns remain robust. Over the past month, Venus Remedies surged by 38.36%, substantially outperforming the Sensex, which declined by 0.46% during the same period. Year-to-date, the sto..."
      },
      {
        "title": "Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-lower-circuit-amid-heavy-selling-pressure-3758809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_stocks_hitting_lower_circuit_3758809.png",
        "date": "2025-12-15 14:00:10",
        "description": "Venus Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 15 Dec 2025 as the stock hit its lower circuit limit, reflecting intense selling pressure and a significant intraday loss of 5.0%. The stock’s performance notably underperformed its sector and the broader market, signalling heightened investor caution and unfilled supply at lower price levels."
      },
      {
        "title": "Venus Remedies Stock Hits All-Time High at Rs.839, Marking a Milestone in Pharmaceuticals Sector",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-stock-hits-all-time-high-of-rs839-on-12-dec-2025-3757363",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_priceRelatedfactors_3757363.png",
        "date": "2025-12-12 10:34:57",
        "description": "Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.839 today, underscoring a remarkable trajectory of growth and resilience in a competitive market environment."
      },
      {
        "title": "Venus Remedies Hits New 52-Week High of Rs.839, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-new-52-week-high-at-rs839-marking-strong-momentum-3757328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_priceRelatedfactors_3757328.png",
        "date": "2025-12-12 10:19:17",
        "description": "Venus Remedies has reached a new 52-week high of Rs.839, reflecting a strong rally in the Pharmaceuticals & Biotechnology sector. This milestone highlights the stock’s sustained momentum, supported by robust financial performance and favourable market conditions."
      },
      {
        "title": "Venus Remedies Hits New 52-Week High of Rs.825, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-new-52-week-high-at-rs825-marking-strong-momentum-3756190",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_priceRelatedfactors_3756190.png",
        "date": "2025-12-11 09:54:10",
        "description": "Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.825 today, underscoring a notable phase of momentum in the stock’s performance. This milestone reflects a sustained upward trend supported by robust financial metrics and market dynamics."
      },
      {
        "title": "Venus Remedies Emerges as a Multibagger Stock with Exceptional Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-a-multibagger-pharma-stock-delivering-exceptional-returns-3756122",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_multibagger_3756122.png",
        "date": "2025-12-11 09:40:07",
        "description": "Venus Remedies Ltd has delivered remarkable returns over multiple time horizons, firmly establishing itself as a multibagger stock within the Pharmaceuticals & Biotechnology sector. The company’s performance has significantly outpaced benchmark indices, reflecting robust financial growth and operational strength."
      },
      {
        "title": "Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-lower-circuit-amid-heavy-selling-pressure-3753488",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_stocks_hitting_lower_circuit_3753488.png",
        "date": "2025-12-09 10:00:16",
        "description": "Venus Remedies Ltd witnessed a sharp decline on 9 Dec 2025, hitting its lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical company’s shares closed near the day’s low, reflecting a maximum daily loss of 4.96%, signalling panic selling and a significant imbalance between supply and demand."
      },
      {
        "title": "Venus Remedies Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-lower-circuit-amid-heavy-selling-pressure-3746619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_stocks_hitting_lower_circuit_3746619.png",
        "date": "2025-12-04 11:00:12",
        "description": "Venus Remedies Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 4 December 2025, resulting in the stock hitting its lower circuit limit. The share price closed at ₹770.0, marking a maximum daily loss and signalling a wave of panic selling that left a significant portion of supply unfilled in the market."
      },
      {
        "title": "Venus Remedies Hits New 52-Week High of Rs.808.5, Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/venus-remedies-hits-new-52-week-high-of-rs8085-marking-significant-milestone-3746120",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/VenusRemedies_priceRelatedfactors_3746120.png",
        "date": "2025-12-04 10:02:43",
        "description": "Venus Remedies, a key player in the Pharmaceuticals & Biotechnology sector, reached a new 52-week high of Rs.808.5 today, underscoring a remarkable rally in its stock price. This milestone reflects sustained momentum driven by strong financial performance and favourable market conditions."
      }
    ],
    "total": 306,
    "sid": "568580",
    "stock_news_url": "https://www.marketsmojo.com/news/venus-remedies-568580"
  },
  "announcements": [
    {
      "caption": "Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares Of Venus Remedies Limited.",
      "datetime": "13-Dec-2025",
      "details": "Social media Post",
      "source": "BSE"
    },
    {
      "caption": "Shares Re-Lodged For Transfer Cum Demat Pursuant To SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod/P/CIR/2025/97 Dated July 2 2025 For The Period July 7 2025 To November 30 2025",
      "datetime": "12-Dec-2025",
      "details": "Status of Physical Transfer request.",
      "source": "BSE"
    },
    {
      "caption": "Venus Remedies Marks Completion Of AMR Licensing Milestones With Final ?11 Crore Payment",
      "datetime": "08-Dec-2025",
      "details": "Announcement as per captioned subject.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Venus Remedies Ltd has declared <strong>30%</strong> dividend, ex-date: 23 Sep 13",
          "dt": "2013-09-23",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views

Why is Venus Remedies falling/rising?

2025-12-18 01:01:12

Short-Term Price Movement and Market Context

Venus Remedies’ share price dropped by ₹28.15 on 17-Dec, marking a 3.53% decrease from the previous close. Intraday, the stock touched a low of ₹758.40, representing a 4.86% fall from its prior levels. This decline is significant given the stock’s recent outperformance relative to the broader market and its sector peers. Over the past week, the stock has declined by 2.23%, while the Sensex benchmark index gained 0.20%, indicating that Venus Remedies underperformed the market in the short term.

Despite this recent dip, the stock’s longer-term returns remain robust. Over the past month, Venus Remedies surged by 38.36%, substantially outperforming the Sensex, which declined by 0.46% during the same period. Year-to-date, the sto...

Read More
stock-recommendationAnnouncement

Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shares Of Venus Remedies Limited.

13-Dec-2025 | Source : BSE

Social media Post

Shares Re-Lodged For Transfer Cum Demat Pursuant To SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod/P/CIR/2025/97 Dated July 2 2025 For The Period July 7 2025 To November 30 2025

12-Dec-2025 | Source : BSE

Status of Physical Transfer request.

Venus Remedies Marks Completion Of AMR Licensing Milestones With Final ?11 Crore Payment

08-Dec-2025 | Source : BSE

Announcement as per captioned subject.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Venus Remedies Ltd has declared 30% dividend, ex-date: 23 Sep 13

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available